ELASTO Sweden continue to grow in medical TPE
ELASTO Sweden, part of the HEXPOL TPE family, continues to grow their medical capabilities with the start-up of a new medical line and expansion to the technical centre at their facility in Åmål, Sweden.
ELASTO Sweden was the first European TPE compounder to be awarded the ISO 13485 certification for the development, manufacture, marketing and sales of TPE compounds for the medical device industry. The new line will be part of their continued focus on medical TPE and supports the sales growth of the Mediprene TPE compounds for medical applications.
Mediprene TPE offer many advantages for medical device applications; they are sterilizable with gamma, EtO and steam. Mediprene TPE are PVC, silicone and latex free, making them allergen free and a viable alternative to PVC based compounds. Applications include medical tubing, IV systems, catheters, respiratory equipment, syringe plunger seals and wound care products.
“High quality materials, produced under consistent conditions with a strict raw material selection policy, all backed by specialist technical support, this is what we’ve built our medical strategy on,” commented Niklas Ottosson, medical technical manager at ELASTO. “Our strong heritage in this sector gives us a deep understanding of medical device regulations and requirements, such as; traceability, reproducibility and formulation stability.”
As part of the investment, ELASTO has also expanded the technical resources at their Swedish facility, Klas Dannäs, Global R&D coordinator for HEXPOL TPE commented “HEXPOL TPE operate technical centres at each of their production sites; ensuring fast and responsive customer support. Our teams of chemists and polymer engineers’ use advanced polymer testing and analysis equipment to develop progressive TPE compounds customised to our customers requirements. To support our growing customer base, we have added to our technical centre in Sweden with the installation of a new pilot line and further investments in analytical equipment such as FTIR, DSC and TGA machines.”
Thomas Nilsson, who joined ELASTO Sweden as managing director earlier this year, added “I have been impressed with the commitment, know-how and dedication of our team. As a supplier to the medical device industry it is critical that we operate to the highest-standards by investing in advanced compounding and product development processes. The new line and investment in technical resources is part of our on-going commitment to supply leading quality TPE products and expertise to our growing medical customer base”
ELASTO Sweden will be exhibiting the latest developments in Mediprene TPE for medical device applications at Compamed, 16 to 19 November, Dusseldorf Hall 8a Stand R14.
About HEXPOL TPE
HEXPOL TPE brings together the ELASTO businesses in Sweden, UK and China and Müller Kunststoffe in Germany. We are at the forefront in the development and manufacture of custom formulated thermoplastic elastomers (TPE) and complimentary compounds. Our family delivers a trusted combination of material know-how, R&D, production capability and comprehensive technical services. As part of the HEXPOL group of companies, we share an extensive global footprint covering EU, Asia-Pacific and NAFTA, enabling us to support our customers worldwide.
A comprehensive product portfolio covering TPS, TPO, TPV, TPU, soft PVC, cork compounds and masterbatch is led by global brands Dryflex®, Mediprene®, Lifoflex®, EPSeal®, Lifolit®, Lifocork®, Lifobatch® and Lifoprene®. We support OEMs, moulders and designers at all stages of product development in the medical, electronic, automotive, caps & closures, construction and consumer markets.
Mediprene®, Dryflex®, EPSeal® , Lifoprene®, Lifoflex®, Lifocork®, Lifolit® and Lifobatch® are registered trademarks property of the HEXPOL group of companies.
For further information please contact:
Jill Bradford, Marketing & PR Manager, HEXPOL TPE
tel +44 161 654 2369 | jill.bradford@hexpolTPE.com